Loss of GSDME effectively ameliorated cisplatin- or ischemia–reperfusion-induced inflammation and acute kidney injury by inhibiting caspase-3/GSDME-induced pyroptosis [59]. This evidence concerns the gene GSDME and acute kidney injury.